Search clinical trials for: ALZ-801 342 mg Fasting

Total 14035 results

Istanbul University

Completed

The Effectiveness of Different Doses of Hyaluronic Acid Injections in Knee Osteoarthritis.

Knee Osteoarthritis

Turkey
PegBio Co., Ltd.

Recruiting

Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)

China, Taiwan, Hong Kong
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine

Migraine With or Without Aura
Vyne Therapeutics Inc.

Completed

Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough

Refractory Chronic Cough

United States, United Kingdom
Shiraz University of Medical Sciences

Completed

Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting

Coronary Stenting

Iran, Islamic Republic of
Universiti Kebangsaan Malaysia Medical Centre

Recruiting

Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting

Fatty Liver Disease

Malaysia
Anni Rahmawati

Unknown

Effect Of Intermittent Fasting To Metabolic And Oxidative Stress Marker

Obesity

Indonesia
Ain Shams University

Completed

Effect of Ramadan Fasting on Muslim Recipients After Living Donor Liver Transplantation

Liver Transplantation

Egypt
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Preventive Therapy for Subjects With Migraine

Migraine
Servier Bio-Innovation LLC
Institut de Recherches Internationales Servier

Recruiting

A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors

Solid Tumor

Spain, Australia, Belgium, United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy

Lymphoma, B-Cell

United States
Centre Hospitalier Universitaire Dijon

Completed

Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma

Child-Pugh A Hepatocellular Carcinoma

France
Ralexar Therapeutics, Inc.

Completed

A Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis | Eczema, Atopic

United States
Merck KGaA, Darmstadt, Germany
Threshold Pharmaceuticals

Completed

A Phase 1 TH-302 Mass Balance Trial

Solid Tumor

Germany
Ashutosh Kumar Tewari

Recruiting

The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting. (PGV-Prostate)

Prostate Cancer

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States
University of California, San Diego

Recruiting

Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2 (PNLABXPART2)

Sepsis | Nephrolithiasis | Urinary Tract Infection (UTI)

United States
Mylan Pharmaceuticals Inc

Completed

Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg

Healthy

United States
Masonic Cancer Center, University of Minnesota

Completed

IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer

FIGO Stage III and IV Ovarian Cancer | FIGO Stage III and IV Fallopian Tube Cancer | FIGO Stage III Primary Peritoneal Cancer

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg

Healthy

United States
Chang Gung Memorial Hospital
Ministry of Health and Welfare, Taiwan

Recruiting

Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma

High Risk of Recurrence

Taiwan
Organon and Co

Completed

An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

Hypercholesterolemia
AstraZeneca

Completed

Phase I, Study in Chinese NSCLC Patients (AURAChinaPK)

Carcinoma, Non-Small-Cell Lung With EGFR Mutation Positive

China
Nottingham Trent University

Recruiting

Extended Evening Fasting: Metabolic Health and Energy Balance

Obesity

United Kingdom
Leap Therapeutics, Inc.
Merck Sharp & Dohme LLC

Completed

A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab (P102)

Esophageal Neoplasms | Gastric Adenocarcinoma | Adenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma | Gastroesophageal Cancer

United States
Hospital de Manises
Merck Sharp & Dohme LLC; Hospital Arnau de Vilanova; Hospital Universitario La... and other collaborators

Unknown

Optimization of Golimumab Treatment in Ulcerative Colitis

Colitis, Ulcerative

Spain
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo

Migraine With or Without Aura
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study

Migraine With or Without Aura
Medibiofarma S.L.

Recruiting

First Phase Clinical Trial of Single Agent MBF-362 in Solid Tumors

Cancer

Spain
Ichnos Sciences SA
Glenmark Pharmaceuticals S.A.

Recruiting

Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

United States, France
Bozyaka Training and Research Hospital

Completed

Effects of Preoperative Fasting on ECG and Vital Parameters

Ischemia | Intraoperative Complications | Fasting

Turkey
Akcea Therapeutics
Ionis Pharmaceuticals, Inc.

Completed

Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

Diabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, Nonalcoholic

United States, Canada
Optimer Pharmaceuticals LLC

Completed

Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001) (DEFLECT-1)

Clostridium Difficile-Associated Diarrhea (CDAD)
Optimer Pharmaceuticals LLC

Completed

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Clostridium Difficile-associated Diarrhea
GlaxoSmithKline

Completed

This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.

Obstetric Labour, Premature

United States
Agios Pharmaceuticals, Inc.

Not yet recruiting

A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy

Sickle Cell Disease | Nephropathy
Sage Therapeutics
Biogen

Active, not recruiting

Study to Evaluate SAGE-324 in Participants With Essential Tremor

Essential Tremor

United States
Maastricht University

Completed

Liver Glycogen Dynamics (LGD)

Hepatic Glycogen

Netherlands
University of Aarhus

Completed

Effects of Fasting and Exercise on Insulin and GH Signaltransduction in Muscle and Fat (FEIGH)

Healthy

Denmark
Free Islamic University of Medical Sciences

Completed

Effect of Fasting With Two Meals on Insulin Resistance Indices of Metabolic Syndrome

Metabolic Syndrome
L-Nutra Inc

Completed

Effect of Fasting-Mimicking Diet on Skin Health

Skin

United States
Tel-Aviv Sourasky Medical Center

Unknown

Intermittent Fasting as a Means to Lose Fluid Overload and Weight in Complicated Obesity

Weight Loss | Obesity, Morbid | Intermittent Fasting | Comorbidities and Coexisting Conditions | Fluid Retention

Israel
The Royal Bournemouth Hospital

Completed

Weight Fluctuation After Breast Cancer Treatment

Breast Cancer | Weight Gain
AstraZeneca

Recruiting

A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC) (TARGET)

Stage II-IIIB Non-small Cell Lung Carcinoma

Spain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
Mutual Pharmaceutical Company, Inc.

Completed

A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions

Healthy

United States
Indiana University

Completed

Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers (COVID-Antibody)

SARS-CoV-2

United States
European Institute of Oncology

Completed

A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus

Pancreatic Neuroendocrine Tumour Metastatic

Italy
Nantes University Hospital

Terminated

Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.

Heavy Proteinuria

France
AstraZeneca

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567.

Rheumatoid Arthritis

Germany, United Kingdom
Wuxi Hisky Medical Technology Co Ltd
Zhongda Hospital, Medical School, Southeast University; Suzhou Municipal Hospital and other collaborators

Recruiting

Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China

Type 2 Diabetes Mellitus in Remission | Metabolic Associated Fatty Liver Disease

China

Search clinical trials for: ALZ-801 342 mg Fasting

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations